Determination of Her-2/Neu status in breast carcinoma: comparative analysis of immunohistochemistry and fluorescent in situ hybridization (Q73409857)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10658908%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Determination of Her-2/Neu status in breast carcinoma: comparative analysis of immunohistochemistry and fluorescent in situ hybridization (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10658908%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

1 reference

Jimenez RE

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10658908%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Wallis T

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10658908%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Tabasczka P

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10658908%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Visscher DW

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10658908%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

publication date

1 January 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10658908%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10658908%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10658908%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10658908%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

37-45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10658908%20AND%20SRC:MED&resulttype=core&format=json

Association of c-erbB-2 protein over-expression with high rate of cell proliferation, increased risk of visceral metastasis and poor long-term survival in breast cancer

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880007

7 January 2021

Significance of c-erbB-2 amplification and DNA aneuploidy. Analysis in 78 patients with node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880007

7 January 2021

The neu-protein and breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880007

7 January 2021

Prognostic significance of HER-2 oncoprotein expression in breast cancer: a 30-year follow-up

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880007

7 January 2021

Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880007

7 January 2021

FISH detection of HER-2/neu oncogene amplification in early onset breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880007

7 January 2021

Fluorescence in situ hybridization for detecting erbB-2 amplification in breast tumor fine needle aspiration biopsies

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880007

7 January 2021

HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880007

7 January 2021

Heterogeneity of chromosome 17 and erbB-2 gene copy number in primary and metastatic bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880007

7 January 2021

Prognostic significance of HER-2/neu gene amplification status by fluorescence in situ hybridization of prostate carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880007

7 January 2021

Detection of chromosome aneuploidy in breast lesions with fluorescence in situ hybridization: comparison of whole nuclei to thin tissue sections and correlation with flow cytometric DNA analysis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880007

7 January 2021

HER-2/neu gene amplification status in prostate cancer by fluorescence in situ hybridization

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880007

7 January 2021

Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880007

7 January 2021

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880007

7 January 2021

Targeting gene transcription: a new strategy to down-regulate c-erbB-2 expression in mammary carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880007

7 January 2021